机构：[1]Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China.[2]Department of Respiratory and Critical Care Medicine, The First People's Hospital of Zunyi City, Zunyi City, Guizhou Province, China.[3]Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.大连医科大学附属第一医院[4]Department of Respiratory and Critical Care Medicine, The People's Hospital of the Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.[5]Department of Respiratory Medicine, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.[6]Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.[7]Department of Pulmonary and Critical Care Medicine Ward 1, Cangzhou Central Hospital, Cangzhou, Hebei, China.[8]Department of Respiratory and Critical Care Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.[9]Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[10]Department of Respiratory and Critical Care Medicine, Guangxi Yulin First People's Hospital, Yulin, Guangxi, China.[11]Department of Respiratory Medicine, Central Hospital in Zhungeer Banner, Muqi Road, Zhungeer Banner, Erdos, Inner Mongolia, China.[12]Department of Respiratory Medicine, People's Hospital of Nanpi County, Nanpi, Hebei, China.[13]Department of Respiratory and Critical Care Medicine, Binzhou People's Hospital, Binzhou, Shandong, China.[14]Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China.内蒙古科技大学包头医学院[15]Department of Respiratory and Critical Care Medicine, Changzhi People's Hospital of Shanxi, Changzhi, Shanxi, China.[16]Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Shanghai, China.[17]Department of Respiratory Medicine, Xi'an Central Hospital Affiliated to Medical College of Xi'an JiaoTong University, Xian, Shanxi, China.[18]Department of Respiratory Medicine, Jinhua Central Hospital of Zhejiang, Jinhua, Zhejiang, China.[19]Department of Respiratory Medicine, Linyi People's Hospital, Linyi, Shandong, China.[20]Department of Respiratory Medicine, Kunming General Hospital of Chengdu Military Command, Kunming, Yunnan, China
Bronchiectasis is a common chronic airway disease. We investigated the economic burden and associated factors of bronchiectasis in China.
In this multicenter retrospective cohort study, we reviewed medical records of patients admitted to 18 tertiary hospitals during 2010 to 2014 with a bronchiectasis-related diagnosis.
A total 5469 patients with bronchiectasis were admitted, accounting for 3.13% ± 1.80% of all discharged patients with any diagnosis during the same period; 13 patients died upon discharge. The median hospitalization cost was RMB 8421.52 (RMB 5849.88-12,294.47). Risk factors associated with hospitalization costs included age at admission (>70 vs. <40 years, odds ratio (OR) = 1.221, 95% confidence interval (CI) = 1.082-1.379; >80 vs. <40 years, OR = 1.251, 95% CI = 1.089-1.438), smoking (≤15 packs/year vs. non-smokers, OR = 1.125, 95% CI = 1.006-1.271; >15 packs/year vs. non-smokers, OR = 1.127, 95% CI = 1.062-1.228), length of hospitalization (OR = 1.05, 95% CI = 1.046-1.054), combination antibiotic treatment (OR = 1.089, 95% CI = 1.033-1.148), cough (OR = 0.851, 95% CI = 0.751-0.965), dyspnea (OR = 0.93, 95% CI = 0.878-0.984), chronic obstructive pulmonary disease (OR = 0.935, 95% CI = 0.878-0.996), respiratory failure (OR = 0.923, 95% CI = 0.862-0.989), cor pulmonale (OR = 0.919, 95% CI = 0.859-0.982), and death (OR = 1.816, 95% CI = 1.113-2.838).
Age, smoking status, symptoms, and respiratory comorbidities were associated with hospitalization costs of bronchiectasis.
基金：
This work was supported by a grant from the
Beijing Higher Education Young Elite Teacher
Project (YETP0071).
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|4 区医学
小类|4 区医学：研究与实验4 区药学
最新[2023]版：
大类|4 区医学
小类|4 区医学：研究与实验4 区药学
JCR分区：
出版当年[2019]版：
Q4MEDICINE, RESEARCH & EXPERIMENTALQ4PHARMACOLOGY & PHARMACY
最新[2023]版：
Q4MEDICINE, RESEARCH & EXPERIMENTALQ4PHARMACOLOGY & PHARMACY
第一作者机构：[1]Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China.[*1]Department of Respiratory and Critical Care Medicine, Peking University People’s Hospital, No. 11 Xizhimen South Street, Xi Cheng District, Beijing 100044, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China.[*1]Department of Respiratory and Critical Care Medicine, Peking University People’s Hospital, No. 11 Xizhimen South Street, Xi Cheng District, Beijing 100044, China
推荐引用方式(GB/T 7714)：
Ma Yanliang,Liu Daishun,Ji Yingqun,et al.Clinical features related to hospital expenses for non-cystic fibrosis bronchiectasis in China.[J].JOURNAL OF INTERNATIONAL MEDICAL RESEARCH.2020,48(6):doi:10.1177/0300060520932116.
APA：
Ma Yanliang,Liu Daishun,Ji Yingqun,Wei Xuemei,Pan Dianzhu...&Fan Manqi.(2020).Clinical features related to hospital expenses for non-cystic fibrosis bronchiectasis in China..JOURNAL OF INTERNATIONAL MEDICAL RESEARCH,48,(6)
MLA：
Ma Yanliang,et al."Clinical features related to hospital expenses for non-cystic fibrosis bronchiectasis in China.".JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 48..6(2020)
